Manoj Bharagava is a “celebratory” and a “pioneer” of the “surgical treatment” for the incurable disease, he told a press conference here on Wednesday.
Bhargava, who has been battling for the last two years to bring his son back to life, told reporters he has “done everything” to make sure his son is “a success” and “happy”.
Bhagava said he has been doing all he can to “make sure the boy becomes a success”.BHAGAVAVA: I have done everything possible to make the boy become a success.
I have gone to all the hospitals.
I even have a team of doctors and nurses at my house.
It’s all been done.
He said his son, who suffers from spina bifida, was born in a “bastard hospital” at a cost of Rs 15 crore in 1996.
He was then aged 3.
He underwent surgery at a private hospital in the city of Bhubaneswar for “a period of time” in 1999.
“At that time, there was no such thing as a spinabifida.
There was no treatment for it.
But I am happy that my son is alive,” Bhagava told reporters.
Bharagava, the founder of the Mumbai-based Surgical Treatment Centre, is a man who “takes a big risk”, he said, adding that his son was not a “trivial” patient.
“But I am very happy because of my son,” he said.BHEGAVAVAV: He has done everything.
I went to all hospitals.
He even has a team, a team that is on site.
It is all done.
BHAGAWA: It is a massive risk and he’s been through everything.
And he is doing well.
But he’s still very far from being able to get a pacemaker.
He will not be able to have it.
Bihar-based surgeon Dr Sushil Sengupta, who had been working for over a decade on a treatment for the disease, has told NDTV that he is still hopeful for a successful recovery for his son.
“There are two patients who have already been operated on, and two more who are expected to be operated on in the next few weeks,” Senguptaso said.
He added that doctors have already begun a series of tests to assess the condition of the patient’s spinal cord.
“They are still looking at the extent of his paralysis and they are also looking at other possible causes, including cancer, but we have not ruled out any of these,” Sagupta said.